AMRX
Price
$8.42
Change
+$0.05 (+0.60%)
Updated
Jul 3 closing price
Capitalization
1.87B
32 days until earnings call
CRON
Price
$2.04
Change
+$0.04 (+2.00%)
Updated
Jul 3 closing price
Capitalization
1B
32 days until earnings call
Interact to see
Advertisement

AMRX vs CRON

Header iconAMRX vs CRON Comparison
Open Charts AMRX vs CRONBanner chart's image
Amneal Pharmaceuticals
Price$8.42
Change+$0.05 (+0.60%)
Volume$898.79K
Capitalization1.87B
Cronos Group
Price$2.04
Change+$0.04 (+2.00%)
Volume$1.94M
Capitalization1B
AMRX vs CRON Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. CRON commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Buy and CRON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AMRX: $8.42 vs. CRON: $2.04)
Brand notoriety: AMRX and CRON are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 47% vs. CRON: 114%
Market capitalization -- AMRX: $1.87B vs. CRON: $1B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileCRON’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • CRON’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 6 TA indicator(s) are bullish while CRON’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 6 bullish, 3 bearish.
  • CRON’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than CRON.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +3.57% price change this week, while CRON (@Pharmaceuticals: Other) price change was +6.81% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

CRON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than CRON($1.01B). AMRX YTD gains are higher at: 6.313 vs. CRON (0.990). AMRX has higher annual earnings (EBITDA): 400M vs. CRON (-71.8M). CRON has more cash in the bank: 862M vs. AMRX (91.5M). CRON has less debt than AMRX: CRON (2.55M) vs AMRX (2.75B). AMRX has higher revenues than CRON: AMRX (2.39B) vs CRON (87.2M).
AMRXCRONAMRX / CRON
Capitalization1.87B1.01B186%
EBITDA400M-71.8M-557%
Gain YTD6.3130.990638%
P/E Ratio90.00N/A-
Revenue2.39B87.2M2,745%
Total Cash91.5M862M11%
Total Debt2.75B2.55M107,756%
FUNDAMENTALS RATINGS
AMRX vs CRON: Fundamental Ratings
AMRX
CRON
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
9984
PRICE GROWTH RATING
1..100
4653
P/E GROWTH RATING
1..100
2879
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (56) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (90) in the Pharmaceuticals Major industry. This means that CRON’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (58) in the Pharmaceuticals Major industry is somewhat better than the same rating for CRON (100) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than CRON’s over the last 12 months.

CRON's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that CRON’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Price Growth Rating (46) in the Pharmaceuticals Major industry is in the same range as CRON (53) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to CRON’s over the last 12 months.

AMRX's P/E Growth Rating (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for CRON (79) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than CRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXCRON
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
69%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
N/A
Bearish Trend 27 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HOOSX29.800.20
+0.68%
Hartford Schroders US Small Cap Opps R4
PBEAX23.750.13
+0.55%
PGIM Jennison Value A
WASAX23.370.10
+0.43%
Macquarie Asset Strategy Fund Cl A
NLSAX19.220.08
+0.42%
Neuberger Berman Long Short A
MUNDX26.300.08
+0.31%
Mundoval

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.60%
PAHC - AMRX
47%
Loosely correlated
+0.21%
VTRS - AMRX
42%
Loosely correlated
-0.21%
EBS - AMRX
40%
Loosely correlated
-1.69%
AMPH - AMRX
40%
Loosely correlated
-1.61%
ZTS - AMRX
39%
Loosely correlated
+0.06%
More

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been loosely correlated with TLRY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+2.00%
TLRY - CRON
61%
Loosely correlated
+11.03%
OGI - CRON
59%
Loosely correlated
+3.62%
CGC - CRON
58%
Loosely correlated
+7.56%
ACB - CRON
56%
Loosely correlated
+1.57%
AMRX - CRON
32%
Poorly correlated
+0.60%
More